US Stock MarketDetailed Quotes
ATNF 180 Life Sciences
- 1.860
- -0.080-4.12%
Close Dec 20 16:00 ET
- 1.830
- -0.030-1.61%
Post 20:01 ET
3.68MMarket Cap-0.61P/E (TTM)
2.020High1.860Low54.55KVolume1.980Open1.940Pre Close107.02KTurnover2.87%Turnover RatioLossP/E (Static)1.98MShares17.75052wk High0.98P/B3.54MFloat Cap1.16052wk Low--Dividend TTM1.90MShs Float4957.214Historical High--Div YieldTTM8.25%Amplitude1.160Historical Low1.961Avg Price1Lot Size
About 180 Life Sciences Company
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Company Profile
SymbolATNF
Company Name180 Life Sciences
Listing DateJun 27, 2017
Founded2016
CEOMr. Blair Jordan
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
Address3000 El Camino Real,Building 4,Suite 200
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94306
Phone1-650-507-0669
Company Executives
- Name
- Position
- Salary
- Blair Jordan
- Director, Interim Chief Executive Officer, Interim Principal Financial and Accounting Officer
- --
- Professor Lawrence J. Steinman, M.D.
- Director
- 253.52K
- Ryan L. Smith
- Independent Director
- --
- Stephen H. Shoemaker
- Independent Director
- --
- Jay Goodman
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data